We read with interest the short communication published in the International Journal
of Cardiology by Constantin-Cristian Topriceanu et al. that investigates the role
of disopyramide in the treatment of left ventricular outflow tract obstruction in
children with hypertrophic cardiomyopathy [
[1]
]. However, we noted an error in the spelling of the term “myectomy”. We believe it
is important to address this error as it could potentially lead to confusion among
readers.Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to International Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Disopyramide is a safe and effective treatment for children with obstructive hypertrophic cardiomyopathy.Int. J. Cardiol. 2023; 371: 523-525
- Laparoscopic myomectomy: a single-center retrospective review of 514 patients.J. Minim. Invasive Gynecol. 2017; 24: 485-493
- Alcohol septal ablation in hypertrophic obstructive cardiomyopathy.Circulation. 2000; 102: 600-601
- Apical myocardial injury caused by collateralisation of a septal artery during ethanol septal ablation.Heart. 2005; 91e2
- Reverse remodeling of left atrium assessed by cardiovascular magnetic resonance feature tracking in hypertrophic obstructive cardiomyopathy after septal myectomy.J. Cardiovasc. Magn. Reson. 2023; 25: 13
Article info
Publication history
Published online: March 22, 2023
Accepted:
March 21,
2023
Received in revised form:
March 13,
2023
Received:
February 28,
2023
Identification
Copyright
© 2023 Elsevier B.V. All rights reserved.
